XLRN
Acceleron Pharma Inc.
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
162 hedge funds and large institutions have $1.93B invested in Acceleron Pharma Inc. in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
-5
Holders Change %
-2.99%
% of All Funds
3.62%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.13%
New
26
Increased
53
Reduced
54
Closed
31
Calls
$27.2M
Puts
$3.66M
Net Calls
+$23.5M
Net Calls Change
-$7.54M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$31.9M |
| 2 |
DM
Deerfield Management
New York
|
+$11.7M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$11.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.1M |
| 5 |
Bank of New York Mellon
New York
|
+$10.9M |
